89,272 Shares in SPDR S&P Biotech ETF $XBI Purchased by Elite Wealth Management Inc.

Elite Wealth Management Inc. purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 89,272 shares of the exchange traded fund’s stock, valued at approximately $14,076,000. SPDR S&P Biotech ETF accounts for approximately 2.7% of Elite Wealth Management Inc.’s portfolio, making the stock its 8th biggest holding.

Other institutional investors have also recently added to or reduced their stakes in the company. Endowment Wealth Management Inc. lifted its holdings in SPDR S&P Biotech ETF by 20.3% during the third quarter. Endowment Wealth Management Inc. now owns 7,709 shares of the exchange traded fund’s stock valued at $1,216,000 after purchasing an additional 1,300 shares in the last quarter. StoneX Group Inc. grew its position in shares of SPDR S&P Biotech ETF by 52.3% in the third quarter. StoneX Group Inc. now owns 7,642 shares of the exchange traded fund’s stock valued at $1,205,000 after purchasing an additional 2,624 shares during the period. Investment Management Corp VA ADV grew its position in shares of SPDR S&P Biotech ETF by 3.8% in the third quarter. Investment Management Corp VA ADV now owns 8,927 shares of the exchange traded fund’s stock valued at $1,408,000 after purchasing an additional 324 shares during the period. Tamar Securities LLC grew its position in shares of SPDR S&P Biotech ETF by 13.0% in the third quarter. Tamar Securities LLC now owns 82,493 shares of the exchange traded fund’s stock valued at $13,008,000 after purchasing an additional 9,522 shares during the period. Finally, United Advisor Group LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth about $289,000.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $152.21 on Monday. SPDR S&P Biotech ETF has a 52 week low of $106.30 and a 52 week high of $169.89. The firm has a 50-day simple moving average of $155.22 and a 200-day simple moving average of $142.29. The stock has a market capitalization of $10.41 billion, a P/E ratio of 11.47 and a beta of 0.87.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.